Kit for the determination of healthy, premutation and mutant alleles in the FMR1 gene by fluorescent fragment analysis

Information about the product

Fragile X Syndrome (FXS, OMIM #300624) is an X-linked disease that is primarily based on the genomic expansion of a triplet of nucleotides (CGG), and aberrant methylation of the promoter region.

FXS has a prevalence of 1 in 4000 males and 1 in 8000 females. Affected individuals show a striking phenotype consisting on large ears and a prominent jaw.

Depending on the number of repetitions of this triplet, four categories can be established:

  • Up to 44 repeats: individuals with healthy alleles.
  • From 45 to 54 repeats: individuals with intermediate alleles.
  • From 55 to 200 repeats: individuals with premutation alleles.
  • Over 200 repeats: individuals with mutant alleles.

Intended Use

Adellgene® Fragile X is a semi-automated in vitro diagnostic kit designed for use in clinical laboratories for the amplification and quantitative determination of CGG triplet repeats (cytosine-guanine-guanine) in the 5’ untranslated region of gene for fragile X mental retardation (“Fragile X mental retardation-1”: FMR1). It aims to aid diagnosis of clinical disease associated with Fragile X syndrome (e.g.: mental retardation, primary ovarian failure, tremors / ataxia, etc …).

The technology is based on the polymerase chain reaction (PCR) amplification of genomic DNA extracted from peripheral blood, followed by fluorescence analysis of the size of the PCR fragments obtained by genetic analyzer.

Patients who can benefit from this determination are those referred by a specialist. The intended user of the kit is technical personnel trained to carry out the protocol and the interpretation of results described in the Instructions for Use.

Workflow

Results

Limitations

  • This kit can quantify all alleles up to 200 CGG repeats.
  • Mutations (point mutations, insertions, deletions) at amplification primer sites are possible and may result in the lack of allele definition. Other technologies could be necessary to resolve the genotyping.
  • Data and result interpretation should be revised by qualified personnel.

Area:

Molecular Genetics, Neurology, Targeted study of specific pathologies

Technology:

Documents:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

Gilbert Syndrome kit FL

Distinguish mutated alleles from wild type alleles through fragment analysis.
Clonit
Fragment Analysis

Twist Comprehensive Exome and Twist Exome 2.0+

Twist Human Comprehensive Exome and Twist Human Exome 2.0+ are two of the capture solutions for human exome sequencing from Twist Bioscience. The combination of Twist's proprietary double-stranded DNA (dsDNA) probes and its library preparation and capture reagents achieves the best market uniformity of coverage and the lowest duplicate rate, generating the highest quality data…
Twist Bioscience
Next Generation Sequencing (NGS)

Genvinset® HLA C*06

Kit for detecting the HLA-C*06 alleles by Real Time PCR using TaqMan® probes technology Information about the product Psoriasis vulgaris is a chronic inflammatory disease of skin, which affects 2% of world population. The cutaneous manifestations of psoriasis are obvious and have a negative impact on quality of life of patients. Family studies have demonstrated…
Blackhills Diagnostic Resources
Real Time PCR (qPCR)

Genvinset® HLA Celiac Plus

Kit para la detección de los alelos HLA-DQB1*02, DQB1*03:02, DQA1*05 y DQA1*03 mediante PCR en tiempo real, Kit for detecting the HLA-DQB1*02, DQB1*03:02, DQA1*05 and DQA1*03 alleles by Real Time PCR using TaqMan® probes technology Information about the product Susceptibility to gluten sensitivity is, in part, genetically determined. The strong predisposition is associated with HLA-DQ…
Blackhills Diagnostic Resources
Real Time PCR (qPCR)